Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

French team presents novel diagnostics for Alzheimer's disease

Oct. 30, 2013

FDA approves GE Healthcare's brain imaging drug for Alzheimer's disease and dementia

Oct. 28, 2013

Bayer Schering Pharma introduces new PET radiopharmaceuticals

Oct. 25, 2013

Phase I data presented on TRAP-based radiopharmaceutical

Oct. 22, 2013

Medical imaging of a radiolabeled anticancer antibody in patients with breast cancer

Oct. 22, 2013

Trovagene enters into pharmaceutical collaboration for oncogene mutation detection study

Oct. 21, 2013

New copper-based diagnostic imaging agents for Alzheimer's disease synthesized

Oct. 21, 2013

Update on phase III investigation of a novel radiotracer for the detection of oral carcinoma

Oct. 18, 2013

Radiotherapy/imaging with trimeric GEBP11 peptide assessed in gastric cancer

Oct. 17, 2013

DiaGenic provides update on two diagnostic tests for AD

Oct. 16, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...